CStone Pharmaceuticals (HKG:2616)
Hong Kong · Delayed Price · Currency is HKD 5.48
+0.07 (1.29%)
Nov 10, 2026, 4:08 PM HKT
CStone Pharmaceuticals Market Cap
CStone Pharmaceuticals has a market cap or net worth of 8.72 billion as of November 9, 2026. It is the 9,459th most valuable company in the world and the 476th biggest in Hong Kong. Its market cap has increased by 9.10% in one year.
Market Cap
8.72B
Enterprise Value
7.26B
Revenue
490.92M
Global Rank
Country Rank
#476 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since February 26, 2019, CStone Pharmaceuticals's market cap has decreased from 12.65B to 8.72B, a decrease of -31.08%. That is a compound annual growth rate of -4.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 8.72B | 12.29% |
| Dec 31, 2025 | 7.77B | 164.57% |
| Dec 31, 2024 | 2.94B | 1.52% |
| Dec 29, 2023 | 2.89B | -47.58% |
| Dec 30, 2022 | 5.52B | -42.71% |
| Dec 31, 2021 | 9.63B | -16.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 10.98B |
| Duality Biotherapeutics | 9.43B |
| Everest Medicines | 9.20B |
| HBM Holdings | 8.87B |
| GenFleet Therapeutics (Shanghai) | 8.34B |
| Shaanxi Micot Pharmaceutical Technology | 8.10B |
| Suzhou Ribo Life Science | 7.36B |
| Nanjing Leads Biolabs | 7.35B |